Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma (2019)
- Authors:
- Autor USP: LINS, JADE CURY MARTINS ASFORA - FM
- Unidade: FM
- DOI: 10.1210/jc.2018-02221
- Subjects: MICOSES; DIAGNÓSTICO TARDIO; LINFOMA; LINFÓCITOS T; NEOPLASIAS CUTÂNEAS; PROGNÓSTICO; ESTUDOS PROSPECTIVOS
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2019
- Source:
- Título: Journal of clinical endocrinology & metabolism
- ISSN: 0021-972X
- Volume/Número/Paginação/Ano: v. 104, n. 8, p. 3245-3248, 2019
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
FALCAO, Camila Kruschewsky et al. Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma. Journal of clinical endocrinology & metabolism, v. 104, n. 8, p. 3245-3248, 2019Tradução . . Disponível em: https://doi.org/10.1210/jc.2018-02221. Acesso em: 10 jan. 2026. -
APA
Falcao, C. K., Cabral, M. C. S., Mota, J. M., Arbache, S. T., Costa-riquetto, A. D., Muniz, D. Q. B., et al. (2019). Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma. Journal of clinical endocrinology & metabolism, 104( 8), 3245-3248. doi:10.1210/jc.2018-02221 -
NLM
Falcao CK, Cabral MCS, Mota JM, Arbache ST, Costa-riquetto AD, Muniz DQB, Cury-martins J, Almeida MQ, Kaczemorska PC, Nery M. Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma [Internet]. Journal of clinical endocrinology & metabolism. 2019 ; 104( 8): 3245-3248.[citado 2026 jan. 10 ] Available from: https://doi.org/10.1210/jc.2018-02221 -
Vancouver
Falcao CK, Cabral MCS, Mota JM, Arbache ST, Costa-riquetto AD, Muniz DQB, Cury-martins J, Almeida MQ, Kaczemorska PC, Nery M. Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma [Internet]. Journal of clinical endocrinology & metabolism. 2019 ; 104( 8): 3245-3248.[citado 2026 jan. 10 ] Available from: https://doi.org/10.1210/jc.2018-02221 - Perforating dermatosis associated with multikinase inhibitors [Carta]: report of two cases, including one associated with lenvatinib
- Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel
- A unique case of a lymphoproliferative disorder affecting the skin and uterine cervix on a male transgender
- Indeterminate cell histiocytosis successfully treated with phototherapy
Informações sobre o DOI: 10.1210/jc.2018-02221 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
